Resources
Show All Related Tags
Did you mean
licensing agreement (801 results), license agreement (548 results), outsourcing agreement (100 results), free-trade agreement (45 results), merger agreement (38 results)more...
Show Fewer Related Tags
Did you mean
licensing agreement (801 results), license agreement (548 results), outsourcing agreement (100 results), free-trade agreement (45 results), merger agreement (38 results), distribution agreement (36 results), settlement agreement (29 results), definitive agreement (20 results), disagreement (10 results), confidentiality agreement (7 results), nondisclosure agreement (2 results)fewer...
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Castle Biosciences Signs Option Agreement for Brain Cancer Test with The University of Texas M.D. Anderson Cancer Center
- - Brain cancer test is a molecular diagnostic test developed and validated at The University of Texas M.D. Anderson Cancer Center to prospectively demonstrate responsiveness to treatment for glioblastoma multiforme GBM, the most common form of primary brain cancer - HOUSTON -- Castle Biosciences, a recently formed, rapidly growing,...
- Research articles 2008-10-07
- Callisto Announces Sponsored Laboratory Study Agreement With M. D. Anderson Cancer Center on Degrasyn Anticancer Agents.
- NEW YORK, June 15 /PRNewswire/ -- - Research Agreement to Support Biological Studies on New Tumor-Fighting Class of Drugs Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health...
- Research articles 2006-06-15
- Callisto Announces Sponsored Research Agreement with M.D. Anderson Cancer Center to Further Development of Degrasyn Anticancer Agents; Research Agreement to Advance Potential New Tumor-Fighting Drugs
- NEW YORK -- Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, announced today that it has executed a sponsored research agreement with the University of Texas M. D. Anderson Cancer Center to support and accelerate development of...
- Research articles 2006-05-10
- Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- M2 PRESSWIRE-12 May 2005-US Financial Network: Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA -...
- Research articles 2005-05-12
- EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- M2 PRESSWIRE-12 May 2005-US Financial Network: EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA...
- Research articles 2005-05-12
- Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas.
- M2 PRESSWIRE-12 May 2005-US Financial Network: Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005...
- Research articles 2005-05-12
- FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- M2 PRESSWIRE-11 May 2005-US Financial Network: FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City...
- Research articles 2005-05-11
- U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M shares.
- M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M sharesC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry,...
- Research articles 2005-05-11
- U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, Arena Pharmaceuticals Shares Rise on Study Results.
- M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, Arena Pharmaceuticals Shares Rise on Study ResultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of...
- Research articles 2005-05-11
- U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, General Dynamics Awarded $51 Million.
- M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, General Dynamics Awarded $51 MillionC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry, CA -...
- Research articles 2005-05-11
- Akorn, Inc. Enters into an Agreement to License a Patent from the University of Texas M.D. Anderson Cancer Center
- BUFFALO GROVE, Ill. -- Akorn, Inc. (AMEX:AKN) today announced that it has entered into the agreement to license a patent entitled "M-EDTA Pharmaceutical Preparations of Uses Thereof" (the "Invention") and related technology rights invented by Issam I. Raad and Robert Sheretz. The license grants Akorn the exclusive rights to develop...
- Research articles 2005-02-17
- Lt. Governor to Keep Eye on Texas University.
- By Patrick McGee, Fort Worth Star-Telegram, Texas Knight Ridder/Tribune Business News May 2--AUSTIN, Texas--Lt. Gov. David Dewhurst plans to preside over meetings every six months with University of Texas System officials and Arlington civic leaders to ensure that the system is bolstering...
- Research articles 2003-05-02
- Collateral Therapeutics announces gene discovery research and license agreement with University of Texas for heart muscle regeneration program.(Brief Article)
- Collateral Therapeutics (San Diego, CA; 858-794-3420) announced that it has entered into an agreement with the University of Texas (Austin, TX) to exclusively license certain human genes discovered by researchers at the UT Southwestern Medical Center (Dallas, TX) and to sponsor additional gene discovery research focused...
- Research articles 2000-09-01
- Norland Medical Systems, Inc. Announces Acquisition Of Worldwide Rights To Proprietary Ultrasound Technology
- WHITE PLAINS, N.Y.--BUSINESS WIRE--JUNE 4, 1996--NORLAND MEDICAL SYSTEMS, INC. (NASDAQ: NRLD) announced today it has entered into a distribution agreement with Vitel, Inc., a privately held Texas corporation affiliated with the University of Texas Southwestern Medical Center at Dallas, which is currently developing bone diagnostic devices using the Ultrasound...
- Research articles 1996-06-04
- CytoGenix and the University of Texas Medical Branch at Galveston Sign Agreement for Preclinical Testing of synDNA™ H5N1 Avian Flu Vaccine Candidates
- HOUSTON -- CytoGenix, Inc. (OTCBB:CYGX) has entered into a research agreement with the University of Texas Medical Branch at Galveston for preclinical animal studies of synDNATM H5N1 vaccine. Dr. Slobodan Paessler, scientific director of the Animal Biosafety Laboratory and the Galveston National Laboratory Advanced Veterinary Services GAVS Core will be...
- Research articles 2006-05-16
- Xpention Genetics Signs Technology License Agreement With The University of Texas MD Anderson Cancer Center
- Xpention Genetics, Inc. (OTC BB: XPNG) and The University of Texas MD Anderson Cancer Center sign a Patent and Technology License Agreement.
- Research articles 2005-04-27
- Xpention Genetics Extends Research Agreement With The University of Texas Health Science Center at San Antonio
- Xpention Genetics, Inc. (OTCBB: XPNG) has extended the Research Agreement with The University of Texas Health Science Center at San Antonio UTHSCSA through May 31, 2007. The extension will permit completion of the research activities for the project entitled "Development of the p65 Immunological Test" as well as permit the...
- Research articles 2007-02-20
- Biokeys Pharmaceuticals, Inc. Announces Expanded Patent and Technology License Agreement with The University of Texas M. D. Anderson Cancer Center
- Business Editors & Health/Medical Writers
- Research articles 2001-06-12
- Agreement for Future of University of Texas at Arlington in the Works.
- By Patrick Mcgee, Fort Worth Star-Telegram, Texas Knight Ridder/Tribune Business News By Patrick Mcgee, Fort Worth Star-Telegram, Texas Knight Ridder/Tribune Business News
- Research articles 2003-04-25
Additional Resources
- Ausam announces commencement of drilling at Vision Chalk Prospect
- TSX Venture Exchange -Symbol "AZE" OTC Bulletin Board - Symbol "ASMEF" HOUSTON, Nov. 18 /PRNewswire-FirstCall/ -- Ausam Energy Corporation ("Ausam" or the "Company") announced today that drilling has commenced on the Rice University A-393 1H well on its Vision Chalk Prospect in Tyler County, Texas. The well...
- Articles 2008-11-18
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
- 5 Ways to Thrive in Today's Business Environment
-
The risk of missed opportunity is high. The cost to implement QlikView is low. Download Free Whitepaper.
- Learn more >>
